New perspectives in the treatment of non-small cell lung cancer (NSCLC)

被引：3

作者：

Brockmoeller, Juergen ^{[1
]}

Junker, Klaus

Multhoff, Gabriele

机构：

[1] Univ Klinikum Gottingen, Klin Pharmakol Abt, Gottingen, Germany

[2] Klinikum Bremen Mitte GmbH, Inst Pathol, Bremen, Germany

[3] Klinikukm Univ Regensburg, Klin & Poliklin Innere Med 1, Abt Hamatol & Onkol, Regensburg, Germany

来源：

ONKOLOGIE | 2006年 / 29卷

关键词：

NSCLC; DNA microarray technology; immunotherapy; HSP70;

D O I：

10.1159/000094952

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：25 / 28

页数：4

共 23 条

[1] Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients [J].

Atanackovic, D ;

Altorki, NK ;

Stockert, E ;

Williamson, B ;

Jungbluth, AA ;

Ritter, E ;

Santiago, D ;

Ferrara, CA ;

Matsuo, M ;

Selvakumar, A ;

Dupont, B ;

Chen, YT ;

Hoffman, EW ;

Ritter, G ;

Old, LJ ;

Gnjatic, S .

JOURNAL OF IMMUNOLOGY, 2004, 172 (05) :3289-3296

[2] CD91: a receptor for heat shock protein gp96 [J].

Binder, RJ ;

Han, DK ;

Srivastava, PK .

NATURE IMMUNOLOGY, 2000, 1 (02) :151-155

[3] Heat-shock protein 72 cell-surface expression on human lung carcinoma cells is associated with an increased sensitivity to lysis mediated by adherent natural killer cells [J].

Botzler, C ;

Issels, R ;

Multhoff, G .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 43 (04) :226-230

[4]

Botzler C, 1998, CELL STRESS CHAPERON, V3, P6, DOI 10.1379/1466-1268(1998)003<0006:DOELEO>2.3.CO

[5]

[6] Molecular genetics of cancer susceptibility [J].

Brockmöller, J ;

Cascorbi, I ;

Henning, S ;

Meisel, C ;

Roots, I .

PHARMACOLOGY, 2000, 61 (03) :212-227

[7] The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells [J].

Gastpar, R ;

Gross, C ;

Rossbacher, L ;

Ellwart, J ;

Riegger, J ;

Multhoff, G .

JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :972-980

[8] Differential up-regulation of cytosolic and membrane-bound heat shock protein 70 in tumor cells by anti-inflammatory drugs [J].

Gehrmann, M ;

Brunner, M ;

Pfister, K ;

Reichle, A ;

Kremmer, E ;

Multhoff, G .

CLINICAL CANCER RESEARCH, 2004, 10 (10) :3354-3364

[9]

Gehrmann M, 2003, HAEMATOLOGICA, V88, P474

[10] Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT1 [J].

Giaccone, G ;

Herbst, RS ;

Manegold, C ;

Scagliotti, G ;

Rosell, R ;

Miller, V ;

Natale, RB ;

Schiller, JH ;

von Pawel, J ;

Pluzanska, A ;

Gatzemeier, M ;

Grous, J ;

Ochs, JS ;

Averbuch, SD ;

Wolf, MK ;

Rennie, P ;

Fandi, A ;

Johnson, DH .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :777-784

← 1 2 3 →